Adaptive Biotechnologies(ADPT) - 2026 Q2 - Earnings Call Transcript
Adaptive Biotechnologies (NasdaqGS:ADPT) Q2 2026 Earnings call July 29, 2026 04:30 PM ET Company ParticipantsKarina Calzadilla - Head of Investor RelationsChad Robins - CEO and Co-founderKyle Piskel - CFONone - Company RepresentativeSubbu Nambi - Managing DirectorCasey Woodring - VP Equity ResearchConference Call ParticipantsDavid Westenberg - Senior Research AnalystMark Massaro - Managing Director, Senior Equity Research AnalystDan Brennan - Senior Equity Research Analyst Managing DirectorKallum Titchmarsh ...